Insider Buying: Teligent Inc (TLGT) Director Purchases 20,000 Shares of Stock

Teligent Inc (NASDAQ:TLGT) Director James C. Gale acquired 20,000 shares of the firm’s stock in a transaction on Thursday, May 23rd. The stock was bought at an average price of $0.69 per share, with a total value of $13,800.00. Following the purchase, the director now directly owns 374,624 shares of the company’s stock, valued at $258,490.56. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

NASDAQ TLGT traded up $0.08 during trading hours on Friday, hitting $0.76. The company had a trading volume of 308,522 shares, compared to its average volume of 499,552. The company has a debt-to-equity ratio of 14.43, a current ratio of 1.46 and a quick ratio of 0.79. Teligent Inc has a 1-year low of $0.66 and a 1-year high of $4.52. The company has a market capitalization of $41.00 million, a PE ratio of -2.31 and a beta of 1.45.

Teligent (NASDAQ:TLGT) last announced its earnings results on Monday, March 18th. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.16). Teligent had a negative return on equity of 103.41% and a negative net margin of 73.56%. The business had revenue of $16.78 million for the quarter, compared to analyst estimates of $17.73 million. On average, research analysts expect that Teligent Inc will post -0.17 earnings per share for the current year.

Several institutional investors and hedge funds have recently made changes to their positions in the company. Elk Creek Partners LLC boosted its stake in shares of Teligent by 6.0% during the fourth quarter. Elk Creek Partners LLC now owns 4,880,589 shares of the company’s stock worth $6,686,000 after buying an additional 277,834 shares during the period. Prosight Management LP boosted its stake in shares of Teligent by 9.5% during the fourth quarter. Prosight Management LP now owns 3,547,607 shares of the company’s stock worth $4,860,000 after buying an additional 306,846 shares during the period. BlackRock Inc. boosted its stake in shares of Teligent by 0.5% during the third quarter. BlackRock Inc. now owns 3,463,605 shares of the company’s stock worth $13,681,000 after buying an additional 16,198 shares during the period. AMI Asset Management Corp boosted its stake in shares of Teligent by 0.5% during the first quarter. AMI Asset Management Corp now owns 2,727,695 shares of the company’s stock worth $3,164,000 after buying an additional 13,403 shares during the period. Finally, Vanguard Group Inc boosted its stake in shares of Teligent by 0.7% during the third quarter. Vanguard Group Inc now owns 2,249,427 shares of the company’s stock worth $8,885,000 after buying an additional 15,800 shares during the period. Institutional investors and hedge funds own 64.59% of the company’s stock.

Several equities analysts have issued reports on TLGT shares. ValuEngine upgraded shares of Teligent from a “hold” rating to a “buy” rating in a research note on Wednesday, May 8th. Raymond James downgraded shares of Teligent from a “strong-buy” rating to an “outperform” rating in a research note on Tuesday, March 19th.

TRADEMARK VIOLATION WARNING: This report was originally reported by Transcript Daily and is owned by of Transcript Daily. If you are accessing this report on another website, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The original version of this report can be viewed at https://transcriptdaily.com/2019/05/25/insider-buying-teligent-inc-tlgt-director-purchases-20000-shares-of-stock.html.

About Teligent

Teligent, Inc, a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. It offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms.

Featured Story: What causes a recession?

Receive News & Ratings for Teligent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent and related companies with MarketBeat.com's FREE daily email newsletter.